BCAL Diagnostics (ASX:BDX) LT-Debt-to-Total-Asset: 0.42 (As of Dec. 2025)


What is BCAL Diagnostics LT-Debt-to-Total-Asset?

BCAL Diagnostics ASX:BDX +4.17% LT-Debt-to-Total-Asset is 0.42 as of Dec. 2025. The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. BCAL Diagnostics's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.42.

BCAL Diagnostics's long-term debt to total assets ratio increased from Dec. 2024 (0.07) to Dec. 2025 (0.42). It may suggest that BCAL Diagnostics is progressively becoming more dependent on debt to grow their business.

BCAL Diagnostics  (ASX:BDX) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

BCAL Diagnostics LT-Debt-to-Total-Asset Related Terms

BCAL Diagnostics LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for BCAL Diagnostics's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics LT-Debt-to-Total-Asset Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
LT-Debt-to-Total-Asset
0.00 0.11 0.09 0.06

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.09 0.07 0.06 0.42

BCAL Diagnostics LT-Debt-to-Total-Asset Calculation

BCAL Diagnostics's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as

LT Debt to Total Assets (A: Jun. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Jun. 2025 )/Total Assets (A: Jun. 2025 )
=0.58/9.909
=0.06

BCAL Diagnostics's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )/Total Assets (Q: Dec. 2025 )
=2.976/7.173
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.42 mean?
BCAL Diagnostics (ASX:BDX) has a LT-Debt-to-Total-Asset of 0.42 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on BCAL Diagnostics and its competitors.
Is BCAL Diagnostics' LT-Debt-to-Total-Asset too high?
BCAL Diagnostics' current LT-Debt-to-Total-Asset is 0.42.
How does BCAL Diagnostics' LT-Debt-to-Total-Asset compare to TMO and DHR?
BCAL Diagnostics' LT-Debt-to-Total-Asset of 0.42 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Diagnostics & Research company?
A good LT-Debt-to-Total-Asset depends on the Medical Diagnostics & Research industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on BCAL Diagnostics and its competitors. BCAL Diagnostics's current LT-Debt-to-Total-Asset is 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BCAL Diagnostics stock overvalued right now?
BCAL Diagnostics (ASX:BDX) has a current LT-Debt-to-Total-Asset of 0.42. The current LT-Debt-to-Total-Asset is 0.42. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For BCAL Diagnostics (ASX:BDX), the current LT-Debt-to-Total-Asset is 0.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BCAL Diagnostics Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.